Sulodexide reduces senescence-related changes in human endothelial cells

Katarzyna Suminska-Jasinska, Alicja Polubinska, Marta Ciszewicz, Adam Mikstacki, Artur Antoniewicz, Andrzej Breborowicz

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: Senescent endothelial cells acquire functional properties that make the vascular wall more prone to atherosclerotic changes. We tested whether senescence of the endothelial cells maintained in in vitro culture can be moderated by their simultaneous exposure to sulodexide. Material/Methods: Replicative aging of the endothelial cells was studied during their 15 passages performed every 4 days in cells cultured in standard medium or in medium supplemented with sulodexide 0.5 LRU/mL. Changes in population doubling time and β-galactosidase activity were used as indexes of aging and compared with other cellular parameters. Results: Repeated passages of endothelial cells induce their senescence, as reflected by prolongation of the population doubling time, increased β-galactosidase activity, oxidative stress and release of cytokines. Healing of the injured endothelial monolayer is impaired in senescent cells. Sulodexide partially prevents oxidative stress and totally eliminates other senescence-related changes such as increased release of MCP-1, lengthening of the population doubling time, and impaired healing of the cellular monolayer after its mechanical injury. Conclusions: Sulodexide prevented cellular senescence in cultured endothelial cells, moderating features of the cellular senescence in endothelial cells in in vitro conditions, which potentially may have practical application. The administration of sulodexide could potentially be used in prevention of atherosclerotic changes.

Original languageEnglish (US)
Pages (from-to)222-226
Number of pages5
JournalMedical Science Monitor
Volume17
Issue number4
StatePublished - 2011
Externally publishedYes

Fingerprint

Endothelial Cells
Galactosidases
Cell Aging
Cultured Cells
Oxidative Stress
Population
Blood Vessels
glucuronyl glucosamine glycan sulfate
Cytokines
Wounds and Injuries
In Vitro Techniques

Keywords

  • Endothelial cells
  • Senescence
  • Sulodexide

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Suminska-Jasinska, K., Polubinska, A., Ciszewicz, M., Mikstacki, A., Antoniewicz, A., & Breborowicz, A. (2011). Sulodexide reduces senescence-related changes in human endothelial cells. Medical Science Monitor, 17(4), 222-226.

Sulodexide reduces senescence-related changes in human endothelial cells. / Suminska-Jasinska, Katarzyna; Polubinska, Alicja; Ciszewicz, Marta; Mikstacki, Adam; Antoniewicz, Artur; Breborowicz, Andrzej.

In: Medical Science Monitor, Vol. 17, No. 4, 2011, p. 222-226.

Research output: Contribution to journalArticle

Suminska-Jasinska, K, Polubinska, A, Ciszewicz, M, Mikstacki, A, Antoniewicz, A & Breborowicz, A 2011, 'Sulodexide reduces senescence-related changes in human endothelial cells', Medical Science Monitor, vol. 17, no. 4, pp. 222-226.
Suminska-Jasinska K, Polubinska A, Ciszewicz M, Mikstacki A, Antoniewicz A, Breborowicz A. Sulodexide reduces senescence-related changes in human endothelial cells. Medical Science Monitor. 2011;17(4):222-226.
Suminska-Jasinska, Katarzyna ; Polubinska, Alicja ; Ciszewicz, Marta ; Mikstacki, Adam ; Antoniewicz, Artur ; Breborowicz, Andrzej. / Sulodexide reduces senescence-related changes in human endothelial cells. In: Medical Science Monitor. 2011 ; Vol. 17, No. 4. pp. 222-226.
@article{6667b935fec34060936eba88a4c2507b,
title = "Sulodexide reduces senescence-related changes in human endothelial cells",
abstract = "Background: Senescent endothelial cells acquire functional properties that make the vascular wall more prone to atherosclerotic changes. We tested whether senescence of the endothelial cells maintained in in vitro culture can be moderated by their simultaneous exposure to sulodexide. Material/Methods: Replicative aging of the endothelial cells was studied during their 15 passages performed every 4 days in cells cultured in standard medium or in medium supplemented with sulodexide 0.5 LRU/mL. Changes in population doubling time and β-galactosidase activity were used as indexes of aging and compared with other cellular parameters. Results: Repeated passages of endothelial cells induce their senescence, as reflected by prolongation of the population doubling time, increased β-galactosidase activity, oxidative stress and release of cytokines. Healing of the injured endothelial monolayer is impaired in senescent cells. Sulodexide partially prevents oxidative stress and totally eliminates other senescence-related changes such as increased release of MCP-1, lengthening of the population doubling time, and impaired healing of the cellular monolayer after its mechanical injury. Conclusions: Sulodexide prevented cellular senescence in cultured endothelial cells, moderating features of the cellular senescence in endothelial cells in in vitro conditions, which potentially may have practical application. The administration of sulodexide could potentially be used in prevention of atherosclerotic changes.",
keywords = "Endothelial cells, Senescence, Sulodexide",
author = "Katarzyna Suminska-Jasinska and Alicja Polubinska and Marta Ciszewicz and Adam Mikstacki and Artur Antoniewicz and Andrzej Breborowicz",
year = "2011",
language = "English (US)",
volume = "17",
pages = "222--226",
journal = "Medical Science Monitor",
issn = "1234-1010",
publisher = "International Scientific Literature Inc.",
number = "4",

}

TY - JOUR

T1 - Sulodexide reduces senescence-related changes in human endothelial cells

AU - Suminska-Jasinska, Katarzyna

AU - Polubinska, Alicja

AU - Ciszewicz, Marta

AU - Mikstacki, Adam

AU - Antoniewicz, Artur

AU - Breborowicz, Andrzej

PY - 2011

Y1 - 2011

N2 - Background: Senescent endothelial cells acquire functional properties that make the vascular wall more prone to atherosclerotic changes. We tested whether senescence of the endothelial cells maintained in in vitro culture can be moderated by their simultaneous exposure to sulodexide. Material/Methods: Replicative aging of the endothelial cells was studied during their 15 passages performed every 4 days in cells cultured in standard medium or in medium supplemented with sulodexide 0.5 LRU/mL. Changes in population doubling time and β-galactosidase activity were used as indexes of aging and compared with other cellular parameters. Results: Repeated passages of endothelial cells induce their senescence, as reflected by prolongation of the population doubling time, increased β-galactosidase activity, oxidative stress and release of cytokines. Healing of the injured endothelial monolayer is impaired in senescent cells. Sulodexide partially prevents oxidative stress and totally eliminates other senescence-related changes such as increased release of MCP-1, lengthening of the population doubling time, and impaired healing of the cellular monolayer after its mechanical injury. Conclusions: Sulodexide prevented cellular senescence in cultured endothelial cells, moderating features of the cellular senescence in endothelial cells in in vitro conditions, which potentially may have practical application. The administration of sulodexide could potentially be used in prevention of atherosclerotic changes.

AB - Background: Senescent endothelial cells acquire functional properties that make the vascular wall more prone to atherosclerotic changes. We tested whether senescence of the endothelial cells maintained in in vitro culture can be moderated by their simultaneous exposure to sulodexide. Material/Methods: Replicative aging of the endothelial cells was studied during their 15 passages performed every 4 days in cells cultured in standard medium or in medium supplemented with sulodexide 0.5 LRU/mL. Changes in population doubling time and β-galactosidase activity were used as indexes of aging and compared with other cellular parameters. Results: Repeated passages of endothelial cells induce their senescence, as reflected by prolongation of the population doubling time, increased β-galactosidase activity, oxidative stress and release of cytokines. Healing of the injured endothelial monolayer is impaired in senescent cells. Sulodexide partially prevents oxidative stress and totally eliminates other senescence-related changes such as increased release of MCP-1, lengthening of the population doubling time, and impaired healing of the cellular monolayer after its mechanical injury. Conclusions: Sulodexide prevented cellular senescence in cultured endothelial cells, moderating features of the cellular senescence in endothelial cells in in vitro conditions, which potentially may have practical application. The administration of sulodexide could potentially be used in prevention of atherosclerotic changes.

KW - Endothelial cells

KW - Senescence

KW - Sulodexide

UR - http://www.scopus.com/inward/record.url?scp=79953673209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953673209&partnerID=8YFLogxK

M3 - Article

C2 - 21455109

AN - SCOPUS:79953673209

VL - 17

SP - 222

EP - 226

JO - Medical Science Monitor

JF - Medical Science Monitor

SN - 1234-1010

IS - 4

ER -